GlassScriptPhysician profile
Bhavtosh Dedania
NPI 1457617656
$39,193.28
in general payments reported to CMS, 2019-2025
44 companies · $26K in 2025
The $26K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,187 · 2020: $659 · 2021: $1,270 · 2022: $1,641 · 2023: $3,403 · 2024: $5,097 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $9,437 · Travel and Lodging: $695 · Education: $9.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,295.00 |
| Food and Beverage | $9,437.24 |
| Travel and Lodging | $694.56 |
| Education | $9.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $26,756.85 | 2024-2025 | Voquezna |
| Abbvie INC. | $3,077.90 | 2019-2025 | Skyrizi, Linzess, Rinvoq |
| Boston Scientific Corporation | $1,371.17 | 2019-2025 | Axios, Spyglass, Autocap Rx |
| Lucid Diagnostics INC. | $861.14 | 2022-2025 | |
| Janssen Biotech, INC. | $832.41 | 2022-2025 | Stelara, Tremfya, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $618.95 | 2021-2025 | Xifaxan, Trulance |
| Genzyme Corporation | $562.23 | 2022-2025 | |
| Pentax of America, INC. | $432.49 | 2020-2023 | C2 Cryoballoon, Arietta 70 |
| Gilead Sciences, INC. | $400.90 | 2020-2025 | Epclusa |
| Takeda Pharmaceuticals U.S.A., INC. | $363.19 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Ardelyx, INC. | $342.68 | 2023-2025 | Ibsrela |
| Celgene Corporation | $301.90 | 2022-2024 | Zeposia |
| Madrigal Pharmaceuticals | $287.92 | 2024-2025 | Rezdiffra, Resmetirom |
| Intra-Sana Laboratories | $266.03 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $235.99 | 2023-2025 | Dupixent |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $217.81 | 2021-2024 | Talicia, Aemcolo |
| Covidien LP | $216.54 | 2019-2020 | |
| Pfizer INC. | $195.75 | 2023-2025 | |
| Daiichi Sankyo INC. | $190.03 | 2020-2022 | |
| Lilly USA, LLC | $176.32 | 2023-2025 | Omvoh |
| Conmed Corporation | $175.76 | 2021-2025 | Conmed Biliary, Conmed Dilation |
| Ironwood Pharmaceuticals, INC | $137.01 | 2021-2023 | Linzess |
| E.R. Squibb & Sons, L.L.C. | $121.82 | 2023 | |
| Steris Corporation | $108.36 | 2021 | |
| Aries Pharmaceuticals, INC. | $90.29 | 2019 | |
| Intercept Pharmaceuticals, INC. | $88.12 | 2022-2025 | Ocaliva |
| Aimmune Therapeutics, INC. | $86.34 | 2024-2025 | Zenpep |
| Axonics, INC. | $86.20 | 2020-2024 | Axonics, Bulkamid |
| Braintree Laboratories, INC. | $68.16 | 2021-2023 | Sutab |
| Medtronic, INC. | $62.20 | 2023-2025 | Interstim, Intellis Adaptivestim |
| Neuraxis, INC. | $57.78 | 2025 | |
| Lumendi LLC | $57.13 | 2020 | |
| Concordia Pharmaceuticals INC. | $52.84 | 2019 | |
| Amgen INC. | $43.11 | 2025 | Uplizna |
| Evoke Pharma, INC. | $42.38 | 2022-2025 | Gimoti |
| Celltrion USA INC. | $39.43 | 2024-2025 | Vegzelma, Zymfentra |
| Fujifilm Healthcare Americas Corporation | $30.95 | 2022 | |
| Novo Nordisk INC | $29.76 | 2025 | Wegovy |
| Pharmacosmos Therapeutics INC. | $27.86 | 2023 | Monoferric |
| Shield Therapeutics INC | $20.57 | 2024 | |
| Alnylam Pharmaceuticals INC. | $18.82 | 2024 | Givlaari |
| Ferring Pharmaceuticals INC. | $16.09 | 2024 | Rebyota |
| Palette Life Sciences, INC. | $14.86 | 2022 | |
| Janssen Pharmaceuticals, INC | $9.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavtosh Dedania listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.